Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Targeting glycosylation to mitigate cancer metastasis: Fulvestrant/Faslodex, a Selective estrogen receptor down-regulator, suppresses the expression of glycosyl transferase Mgat4a (Mannoside acetylglucosaminyltransferase 4, isoenzyme A) via up regulation of its target gene, 30/April/2014, 6.18 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation